Abiopharma

Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis

Commerce Bank to Acquire Nolan & Associates, Adding Investment Banking Capabilities for Middle-Market Clients

Sharon AI Announces Closing of US$1.6 Billion Strategic Financing

ADP to Announce Fourth Quarter Fiscal 2026 Financial Results on July 29, 2026

Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes

BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility

Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy

Palantir and Surf Air Mobility Expand Partnership to Accelerate Commercialization of OperatorOS, OwnerOS, and Enterprise Products

Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen

Palantir Launches Engine for Deploying NVIDIA Nemotron Open Models in Sovereign Environments